Sign In
Buy LLY
$1,131.42
+6.15 (+0.547%)
At Close: Jun 05, 2026
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
07:23am, Tuesday, 27'th Aug 2024
Eli Lilly will offer weight-loss drug Zepbound in a new form at roughly half the list price. Eli Lilly stock fell, along with several others.
Eli Lilly says patients can now access 2.5 mg and 5 mg vials of weight-loss drug Zepbound for at least 50% discount
06:56am, Tuesday, 27'th Aug 2024
Eli Lilly & Co. LLY, -0.23% said Tuesday patients can now access 2.5 mg and 5 mg single-dose vials of its weight-loss treatment Zepbound with an on-label prescription at a discount of at least 50% ove
Lilly launches single-dose vials of Zepbound for weight loss to expand US supply
06:49am, Tuesday, 27'th Aug 2024
Eli Lilly said it has begun selling single-dose vials of its popular weight-loss drug Zepbound in the U.S., aimed at patients who cannot get the cost of the medicine reimbursed through their health in
Pfizer follows Eli Lilly's lead in direct-to-consumer push
06:47am, Tuesday, 27'th Aug 2024
Pfizer Inc. on Tuesday unveiled a new online platform designed to help simplify and coordinate healthcare for consumers, adding momentum to an emerging trend in big pharma that has drawn criticism fro
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
06:45am, Tuesday, 27'th Aug 2024
Eli Lilly released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to increase access for patients without insurance coverage for the highly popular injection
Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity
06:45am, Tuesday, 27'th Aug 2024
Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity INDIANAPOLIS , Aug. 27, 2024 /P
Market Navigator: Playing Big Pharma and Eli Lilly
03:25pm, Monday, 26'th Aug 2024
Kate Stockton, Fairlead Strategies founder, joins 'Power Lunch' to discuss how to play Big Pharma stocks and Eli Lilly.
Buy 4 Top-Ranked Stocks to Play Likely Earnings Beat
12:35pm, Monday, 26'th Aug 2024
Top-ranked stocks Norwegian Cruise Line (NCLH), Eli Lilly (LLY), The Progressive (PGR) and Fortinet (FTNT) are likely to beat on earnings in their upcoming releases.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:05am, Monday, 26'th Aug 2024
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Eli Lilly's Path to the Next Trillion Market Capitalization
09:46am, Monday, 26'th Aug 2024
Eli Lilly and Co. NYSE: LLY is a pharmaceutical giant that's made headlines for its GLP-1/GIP weight loss drug Tirzepatide, known as Mounjaro for type 2 diabetes, and Zepbound for obesity. Its stock i
Mounjaro Scores Yet Another Win: Why Eli Lilly Is Still a Buy
07:10am, Sunday, 25'th Aug 2024
Eli Lilly's crown jewel performed well in another pivotal clinical trial. The medicine's potential looks even more attractive than it already did.
5 Best CEFs This Month For Nearly 9% Yield (August 2024)
09:00am, Saturday, 24'th Aug 2024
For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs,
Prediction: These Will Be the Best-Performing S&P 500 Stocks of 2024
05:50am, Saturday, 24'th Aug 2024
2024's best-performing S&P 500 stock so far should keep its top spot with a blow-out quarterly update this month. The No. 2 S&P 500 stock should continue to enjoy a massive tailwind throughout the res
Eli Lilly Alzheimer's drug to be blocked for use by NHS, The Telegraph reports
05:18pm, Friday, 23'rd Aug 2024
Eli Lilly's treatment for early Alzheimer's is expected to be blocked for use by Britain's National Health Service (NHS), The Telegraph reported on Friday.
Stock Market This Week: Powell Fuels Rally, TGT Flexes Retail Strength, LLY Drug Trial Success
05:12pm, Friday, 23'rd Aug 2024
A back-and-forth week in the markets turned to the upside when Fed Chair Jerome Powell shared optimism during his speech at Jackson Hole. Target (TGT) led the charge in retail strength, while Eli Lill
